Literature DB >> 29660423

Hair disorders in cancer survivors.

Azael Freites-Martinez1, Jerry Shapiro2, Corina van den Hurk3, Shari Goldfarb4, Joaquin J Jimenez5, Anthony M Rossi1, Ralf Paus6, Mario E Lacouture7.   

Abstract

With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy-induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  alopecia; cancer survivors; cancer therapy; endocrine therapy; hirsutism; hypertrichosis; persistent alopecia; persistent chemotherapy-induced alopecia; persistent radiotherapy-induced alopecia; quality of life; therapeutic transplants

Mesh：

Substances：

Year:  2018        PMID： 29660423      PMCID： PMC6186205          DOI： 10.1016/j.jaad.2018.03.056

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  95 in total

Review 1.  Keloids and hypertrophic scars.

Authors:  R S English; P D Shenefelt
Journal:  Dermatol Surg       Date:  1999-08       Impact factor: 3.398

2.  Hair follicle biology, the sebaceous gland, and scarring alopecias.

Authors:  K S Stenn; J P Sundberg; L C Sperling
Journal:  Arch Dermatol       Date:  1999-08

3.  Oral-cavity hair growth after free-flap transfer: case report.

Authors:  T Endo; Y Nakayama; M Kikuchi
Journal:  J Reconstr Microsurg       Date:  2001-01       Impact factor: 2.873

4.  Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.

Authors:  M E de Jonge; R A A Mathôt; O Dalesio; A D R Huitema; S Rodenhuis; J H Beijnen
Journal:  Bone Marrow Transplant       Date:  2002-11       Impact factor: 5.483

5.  Influence of estrogens on the androgen metabolism in different subunits of human hair follicles.

Authors:  S Niiyama; R Happle; R Hoffmann
Journal:  Eur J Dermatol       Date:  2001 May-Jun       Impact factor: 3.328

6.  Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.

Authors:  G Socié; R A Clift; D Blaise; A Devergie; O Ringden; P J Martin; M Remberger; H J Deeg; T Ruutu; M Michallet; K M Sullivan; S Chevret
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

7.  Permanent alopecia following chemotherapy and bone marrow transplantation.

Authors:  D Tran; R D Sinclair; A P Schwarer; C W Chow
Journal:  Australas J Dermatol       Date:  2000-05       Impact factor: 2.875

8.  Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors.

Authors:  A L Albright; R Sposto; E Holmes; P M Zeltzer; J L Finlay; J H Wisoff; M S Berger; R J Packer; I F Pollack
Journal:  Neurosurgery       Date:  2000-10       Impact factor: 4.654

Review 9.  Molecular genetic and endocrine mechanisms of hair growth.

Authors:  Laura C Alonso; Robert L Rosenfield
Journal:  Horm Res       Date:  2003

10.  Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

Authors:  Gottfried Konecny; Giovanni Pauletti; Mark Pegram; Michael Untch; Sugandha Dandekar; Zuleima Aguilar; Cindy Wilson; Hong-Mei Rong; Ingo Bauerfeind; Margret Felber; He-Jing Wang; Malgorzata Beryt; Ram Seshadri; Herrmann Hepp; Dennis J Slamon
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506
View more
  13 in total

1.  Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers.

Authors:  Jenna R Stoehr; Cory Kosche; Jennifer N Choi
Journal:  Support Care Cancer       Date:  2019-11-19       Impact factor: 3.603

2.  Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT).

Authors:  Danbee Kang; Im-Ryung Kim; Yeon Hee Park; Young Hyuck Im; Di Zhao; Eliseo Guallar; Jin Seok Ahn; Juhee Cho
Journal:  Support Care Cancer       Date:  2019-07-23       Impact factor: 3.603

3.  TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression.

Authors:  Tingting Song; Hong Wang; Yue Liu; Rongshan Cai; Dezhi Yang; Yongai Xiong
Journal:  Int J Nanomedicine       Date:  2021-09-14

4.  Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors.

Authors:  Daniela Doege; Melissa S Y Thong; Lena Koch-Gallenkamp; Heike Bertram; Andrea Eberle; Bernd Holleczek; Alice Nennecke; Ron Pritzkuleit; Annika Waldmann; Sylke R Zeissig; Hermann Brenner; Volker Arndt
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-25       Impact factor: 4.322

5.  Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review.

Authors:  Taylor Novice; Madison Novice; David Portney; Joshua Goyert; N Lynn Henry; Jacqueline S Jeruss; Monika L Burness
Journal:  Support Care Cancer       Date:  2022-07-23       Impact factor: 3.359

6.  Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer.

Authors:  Gregory S Phillips; Morgan E Freret; Danielle Novetsky Friedman; Sabrina Trelles; Oluwaseun Kukoyi; Azael Freites-Martinez; Robin H Unger; Joseph J Disa; Leonard H Wexler; Christopher L Tinkle; James G Mechalakos; Stephen W Dusza; Kathryn Beal; Suzanne L Wolden; Mario E Lacouture
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

7.  Flame Hair: Auxiliary Trichoscopic Finding in Radiotherapy-Induced Alopecia.

Authors:  Ana Beatriz Silva Lima; Fernanda Tirelli Rocha; Fernanda André Martins Cruz Perecin; João Carlos Lopes Simão; Andrezza Telles Westin; Marco Andrey Cipriani Frade
Journal:  Skin Appendage Disord       Date:  2021-02-18

8.  Giving A Face to Chemotherapy-Induced Alopecia: A Feasibility Study on Drawings by Patients.

Authors:  Kirsten van Alphen; Anne Versluis; Wouter Dercksen; Henk de Haas; Rieneke Lugtenberg; Jitske Tiemensma; Judith Kroep; Elizabeth Broadbent; Ad A Kaptein; Corina van den Hurk
Journal:  Asia Pac J Oncol Nurs       Date:  2020-03-30

9.  Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy.

Authors:  Jin Yong Kim; Jungyoon Ohn; Ji-Seon Yoon; Bo Mi Kang; Minji Park; Sookyung Kim; Woochan Lee; Sungjoo Hwang; Jong-Il Kim; Kyu Han Kim; Ohsang Kwon
Journal:  Nat Commun       Date:  2019-08-27       Impact factor: 14.919

Review 10.  Restorative oncodermatology: Diagnosis and management of dermatologic sequelae from cancer therapies.

Authors:  Anthony M Rossi; Brian P Hibler; Cristian Navarrete-Dechent; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-08-08       Impact factor: 15.487
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.